APA (7th ed.) Citation

S, I., I, I., M, B., & S, K. (2019). mRNA Expression Profile of SFKs and Involvement of SFKs in the Regulation of LPS-Induced Erk1/2 Signaling in PBMCs of Active BD Patients. Endocrine, metabolic & immune disorders drug targets, 19(6), 809. https://doi.org/10.2174/1871530319666190119101756

Chicago Style (17th ed.) Citation

S, Irtegun-Kandemir, Icen-Taskin I, Bozkurt M, and Kalkanli-Tas S. "MRNA Expression Profile of SFKs and Involvement of SFKs in the Regulation of LPS-Induced Erk1/2 Signaling in PBMCs of Active BD Patients." Endocrine, Metabolic & Immune Disorders Drug Targets 19, no. 6 (2019): 809. https://doi.org/10.2174/1871530319666190119101756.

MLA (9th ed.) Citation

S, Irtegun-Kandemir, et al. "MRNA Expression Profile of SFKs and Involvement of SFKs in the Regulation of LPS-Induced Erk1/2 Signaling in PBMCs of Active BD Patients." Endocrine, Metabolic & Immune Disorders Drug Targets, vol. 19, no. 6, 2019, p. 809, https://doi.org/10.2174/1871530319666190119101756.